搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medscape
6 小时
Older Anti-Obesity Meds Offer Options Amid Low Access to GLP-1s
While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...
Medscape
4 小时
New Data Shed Light on Who Stops Using GLP-1 Drugs, and Why
A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.
1 小时
on MSN
Best Health Care Stocks to Watch in February 2025
These are some of the best-performing stocks in the health care sector over the past month The health care sector is massive ...
Frontiers
16 分钟
Exploring the Interplay Between Stress, Neuropeptides, and Alcohol Use Disorder
Alcoholism and alcohol use disorder (AUD) are major public health and socioeconomic issues. However, a handful of ...
Psychology Today
17 小时
New Weight Loss Medications May Help Treat Addiction
New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...
technologynetworks
15 小时
Weight Loss and Diabetes Drugs: What’s the Latest Research?
Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...
Knowridge
5 小时
New breakthroughs in diabetes treatment
One of the most exciting developments in diabetes treatment is the use of new medications that help control blood sugar in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈